Pelvic Organ Prolapse (POP)

1. Clinical Overview

Summary

Pelvic Organ Prolapse (POP) is the descent or herniation of pelvic organs (bladder, uterus, rectum, small bowel) into or beyond the vaginal walls due to failure of the endopelvic fascia and levator ani muscle complex. It represents a common condition affecting approximately 40-50% of parous women, with clinically significant prolapse (beyond the hymen) present in 3-6% of women. [1,2]

The condition exists on a spectrum from asymptomatic anatomical findings to severe prolapse causing significant functional impairment and reduced quality of life. While not life-threatening in most cases, severe prolapse can lead to urinary tract obstruction, renal impairment, and profound impact on sexual, urinary, and bowel function. [3]

Management is individualized and ranges from expectant observation through conservative measures (pelvic floor muscle training, pessaries) to surgical intervention. The choice depends on symptom severity, patient preferences, surgical fitness, and desire for future fertility. [4,5]

Clinical Pearls

The "Dragging" Sensation: The pathognomonic symptom is the sensation of "something coming down" or "sitting on a ball". Symptoms are characteristically gravity-dependent—minimal or absent on waking, progressively worsening throughout the day with upright posture and straining, and improving with recumbency.

Renal Failure Risk: In severe procidentia (grade 4 prolapse), bladder descent can cause ureteric kinking at the pelvic brim or vesicoureteric junction, leading to silent bilateral hydronephrosis and progressive chronic kidney disease. Always assess renal function (serum creatinine, eGFR) and consider renal ultrasound in advanced prolapse. [6]

Occult Stress Incontinence: Paradoxically, severe anterior prolapse may compress and kink the urethra, masking underlying stress urinary incontinence (SUI). When prolapse is reduced (surgically or with pessary), up to 20-40% of women develop de novo SUI—termed "occult" or "masked" stress incontinence. Preoperative urodynamic assessment with prolapse reduction is essential before surgical repair. [7,8]

Digitation: The need for manual reduction of prolapse or perineal/vaginal splinting to facilitate defecation is highly specific for posterior compartment prolapse (rectocele) and indicates significant functional impairment. [9]

---

2. Epidemiology

Prevalence

• Overall prevalence: 40-50% of parous women have some degree of pelvic organ descent on examination, though many are asymptomatic. [1,2]
• Clinically significant prolapse (beyond hymen): 3-6% of women.
• Symptomatic prolapse: Affects approximately 12.8% of women in community-based studies. [10]
• Age distribution: Prevalence increases significantly with age—present in approximately 30% of women aged 50-59 years, rising to over 50% in women over 80 years. [11]

Incidence

• Lifetime risk of undergoing prolapse surgery: 11-19% by age 80. [12]
• Risk of repeat surgery for recurrent prolapse: 29-40% within 10 years of initial repair. [13]

Geographic and Ethnic Variation

• Higher prevalence reported in Caucasian and Hispanic women compared to African American and Asian women, though this may reflect differences in healthcare access and reporting. [14]
• Cultural factors influence symptom reporting and treatment-seeking behavior.

Risk Factors

Established Risk Factors

1. Parity and Mode of Delivery [15,16]

• Nulliparity: Baseline risk ~1%
• One vaginal delivery: Odds ratio (OR) 4.0-5.5
• Two or more vaginal deliveries: OR 8.0-12.0
• Each additional vaginal birth increases risk incrementally
• Caesarean delivery reduces but does not eliminate risk (OR ~2.0 compared to nulliparity)
• Delivery trauma: Forceps delivery (OR 1.6-2.1), prolonged second stage (> 2 hours, OR 1.4-1.9), large fetal birth weight (> 4000g, OR 1.3-1.5)

2. Age and Menopause [17]

• Risk increases by 30-40% per decade of life
• Estrogen deficiency leads to:
  • Collagen degradation and reduced tissue elasticity
  • Vaginal atrophy and weakening of endopelvic fascia
  • Reduced pelvic floor muscle strength

3. Obesity [18]

• Body Mass Index (BMI) > 25: OR 1.4-1.6
• BMI > 30: OR 2.0-2.5
• Each 5-unit increase in BMI increases prolapse risk by 30-50%
• Mechanism: Chronic elevation of intra-abdominal pressure

4. Chronic Increased Intra-Abdominal Pressure

• Chronic obstructive pulmonary disease (COPD) with chronic cough: OR 1.5-2.0 [19]
• Chronic constipation and straining: OR 1.3-1.8 [20]
• Heavy occupational lifting: OR 1.3-1.6
• Chronic ascites (less common)

5. Genetic and Connective Tissue Factors [21,22]

• Family history of prolapse: OR 2.0-3.0
• Hereditary connective tissue disorders:
  • Ehlers-Danlos syndrome (especially hypermobility type)
  • Marfan syndrome
  • Joint hypermobility spectrum disorders
• Collagen gene polymorphisms (COL1A1, COL3A1) associated with increased risk

6. Previous Pelvic Surgery

• Prior hysterectomy: OR 2.0-5.8 for subsequent vault prolapse [23]
• Vaginal hysterectomy carries higher vault prolapse risk than abdominal approach
• Previous prolapse surgery (due to tissue weakness and recurrence)

7. Other Factors

• Race/ethnicity: Higher in Caucasian and Hispanic women
• Menstrual history: Irregular menses, early menarche (conflicting evidence)
• Hormonal factors: Low estrogen states

Protective Factors

• Elective caesarean section (though not absolute protection)
• Regular pelvic floor muscle exercises
• Maintenance of healthy weight
• Treatment of chronic cough and constipation

---

3. Pathophysiology

Normal Pelvic Support Anatomy

Pelvic organ support depends on an integrated three-tiered system:

Level I Support (Apical Suspension) [24]

• Uterosacral-cardinal ligament complex: Primary suspension of uterus and upper vagina
• Extends from cervix/upper vagina to sacrum and lateral pelvic sidewall
• Failure → Uterine prolapse, vaginal vault prolapse, enterocele

Level II Support (Mid-Vaginal Attachment)

• Arcus tendineus fasciae pelvis (ATFP): "White line" extending from pubic bone to ischial spine
• Lateral attachment of endopelvic fascia
• Anteriorly: Supports bladder (pubocervical fascia)
• Posteriorly: Supports rectum (rectovaginal fascia)
• Failure → Cystocele (anterior), Rectocele (posterior)

Level III Support (Distal Fusion)

• Distal vagina fuses with:
  • Urogenital diaphragm (anteriorly)
  • Perineal body (posteriorly)
  • Levator ani muscles (laterally)
• Failure → Perineal descent, low rectocele

Levator Ani Muscle Complex [25]

• Active muscular component providing dynamic support
• Maintains constant baseline tone ("closing force")
• Components: Pubococcygeus, puborectalis, iliococcygeus
• Innervation: Pudendal nerve (S2-S4) and direct branches from sacral plexus
• Damage during childbirth (avulsion, denervation) critically weakens pelvic floor

Pathophysiological Mechanisms of Prolapse

1. Biomechanical Failure [26]

• Chronic or acute disruption of fascial and ligamentous support
• Loss of normal vaginal axis (horizontal upper vagina becomes vertical)
• Increased load on remaining intact structures
• Progressive "cascade" effect as one compartment failure increases stress on others

2. Collagen Abnormalities [21,22]

• Altered collagen I:III ratio in prolapse patients
• Increased matrix metalloproteinase (MMP) activity
• Reduced tensile strength of pelvic fascia
• Genetic predisposition to collagen weakness

3. Neuromuscular Injury [27]

• Pudendal nerve stretch/compression during vaginal delivery
• Denervation atrophy of levator ani muscles
• Direct avulsion of levator ani from pubic bone (10-30% of first vaginal deliveries)
• Loss of tonic muscle support and reflexive contraction

4. Hormonal Changes [17]

• Estrogen receptor expression in pelvic floor tissues
• Postmenopausal estrogen deficiency leads to:
  • Reduced collagen synthesis
  • Decreased tissue thickness and elasticity
  • Vaginal atrophy and weakening

5. Chronically Elevated Intra-Abdominal Pressure

• Acts as repetitive loading stress on pelvic floor
• Analogous to abdominal wall hernia development
• Mechanisms: Obesity, COPD, chronic constipation, heavy lifting

Anatomical Classification by Compartment

Anterior Compartment (Most Common, ~50-60% of prolapse)

• Cystocele: Descent of bladder base and trigone through anterior vaginal wall
• Mechanism: Failure of pubocervical fascia and detachment from ATFP
• Subtypes:
  • "Central defect: Midline fascial attenuation"
  • "Lateral defect: Paravaginal detachment from ATFP (less common)"
  • "Apical defect: Loss of level I support causing anterior and apical descent together"

Posterior Compartment (~30-40% of prolapse)

• Rectocele: Descent of rectum through posterior vaginal wall
• Mechanism: Failure of rectovaginal fascia
• Subtypes:
  • "High/mid rectocele: Rectovaginal fascia attenuation"
  • "Low rectocele: Perineal body weakness (Level III failure)"
• Enterocele: Herniation of peritoneal sac (containing small bowel or omentum) between uterus/vaginal vault and rectum
  • Often associated with apical prolapse
  • Can be difficult to distinguish from high rectocele clinically

Apical Compartment (~30% of prolapse)

• Uterine prolapse: Descent of uterus (in women with intact uterus)
• Vaginal vault prolapse: Descent of vaginal apex after hysterectomy
• Mechanism: Failure of uterosacral-cardinal ligament complex (Level I)
• Often accompanied by anterior and/or posterior compartment prolapse ("pan-vaginal prolapse")

Combined Prolapse

• Majority of women have multi-compartment prolapse
• Isolated single-compartment prolapse is uncommon
• Leading edge (most descended compartment) determines predominant symptoms

---

4. Differential Diagnosis

Vaginal/Pelvic Mass Differential

---

5. Clinical Presentation

Symptom Profile

Symptoms correlate poorly with anatomical severity—some women with advanced prolapse are minimally symptomatic, while others with modest descent have significant symptoms. [28]

Pelvic/Vaginal Symptoms (Most Specific)

"Bulge" Symptoms (85-95% of symptomatic women) [29]

• Sensation of vaginal lump or "something coming down"
• Feeling of pressure or heaviness in pelvis/vagina
• "Sitting on a ball" or "falling out" sensation
• Visibility or palpability of bulge at introitus (in advanced cases)
• Characteristics:
  • Worse at end of day
  • Worse after prolonged standing, walking, lifting
  • Improves when lying down
  • Exacerbated by coughing, straining, exercise

Sexual Dysfunction [30]

• Dyspareunia (pain during intercourse) or obstruction
• Reduced libido due to self-consciousness
• Reduced sensation or partner awareness of prolapse
• Avoidance of sexual activity

Urinary Symptoms (60-80% of symptomatic women)

Lower Urinary Tract Symptoms (LUTS) [31]

• Obstructive symptoms:
  • Incomplete bladder emptying sensation
  • Hesitancy, weak stream
  • Need to manually reduce prolapse to initiate or complete voiding (manual reduction)
  • Position-dependent voiding (unable to void unless prolapse reduced)
  • Urinary retention (severe cases)
• Irritative symptoms:
  • Frequency (> 8 voids/day), nocturia
  • Urgency, urge incontinence
• Stress urinary incontinence:
  • May coexist with prolapse
  • May be masked by severe anterior prolapse (occult SUI)
  • May develop de novo after prolapse repair

Recurrent Urinary Tract Infections

• Incomplete bladder emptying predisposes to infection
• Chronic indwelling pessaries can increase UTI risk

Bowel Symptoms (30-50% of symptomatic women)

Posterior Compartment-Specific Symptoms [9,32]

• Obstructed defecation:
  • Sensation of incomplete rectal emptying
  • Straining to defecate
  • "Splinting/Digitation: Manual pressure on posterior vaginal wall, perineum, or perianal area to facilitate defecation (highly specific for rectocele)"
  • Prolonged time on toilet
• Constipation (causative and consequence)
• Fecal incontinence (less common; may indicate concurrent anal sphincter dysfunction)

Enterocele-Specific Symptoms

• Pelvic pain or dragging sensation when standing
• Relief when lying down (bowel contents reduce)

General Symptoms

• Pelvic pain/discomfort: Dull, aching, worse with standing
• Back pain: Lower back discomfort (non-specific)
• Reduced physical activity: Due to bulge discomfort
• Psychosocial impact: Embarrassment, social isolation, depression, reduced quality of life

Asymptomatic Prolapse

• Many women with anatomical prolapse (especially grade 1-2) are asymptomatic
• Asymptomatic prolapse does not require treatment
• May be incidental finding during routine gynecological examination

---

6. Clinical Examination

History Taking

• Presenting symptoms: Bulge, urinary, bowel, sexual symptoms
• Severity and impact: Effect on activities of daily living, quality of life, work, exercise
• Temporal pattern: Duration, progression, variability
• Obstetric history: Number of vaginal deliveries, instrumental deliveries, birth weights, complications
• Medical history: COPD, constipation, connective tissue disorders
• Surgical history: Previous pelvic surgery, hysterectomy
• Medications: Constipating medications, diuretics
• Lifestyle: Occupation (heavy lifting), exercise, smoking
• Desire for future fertility: Critical for surgical planning

Physical Examination

General Examination

• BMI assessment
• Abdominal examination: Exclude masses, ascites

Pelvic Examination

1. External Inspection

• Inspect vulva and introitus at rest and with straining (Valsalva)
• Assess perineal body integrity
• Assess for concurrent conditions (atrophy, dermatoses, labial pathology)

2. Sims Speculum Examination (Essential) [33]

• Patient in left lateral position (Sims position) or dorsal lithotomy
• Technique:
  • Insert Sims speculum (single-bladed) to retract posterior vaginal wall
  • Ask patient to cough and strain (Valsalva maneuver)
  • Assess anterior compartment (bladder/cystocele) and apex (uterus/vault)
  • Remove speculum and reinsert to retract anterior wall
  • Assess posterior compartment (rectocele/enterocele)
• Findings to document:
  • Maximum descent of each compartment (anterior, posterior, apical)
  • Grade of prolapse (see below)
  • Presence of ulceration, erosion, bleeding
  • Ability to reduce prolapse manually

3. Bimanual Examination

• Assess uterine size, mobility, masses (fibroids)
• Assess adnexal masses
• Assess pelvic organ mobility and support

4. Rectal Examination (if posterior symptoms)

• Assess rectocele (bulge into anterior rectal wall)
• Differentiate rectocele from enterocele (enterocele may have palpable bowel loops or feel empty)
• Assess anal sphincter tone (if fecal incontinence present)

5. Pelvic Floor Muscle Assessment

• Assess ability to contract pelvic floor muscles (voluntary squeeze)
• Grading: Oxford scale (0-5) or PERFECT scheme
• Important for determining suitability for pelvic floor muscle training

6. Stress Test for Urinary Incontinence

• With full bladder, ask patient to cough
• Observe for urethral urine leakage
• Repeat with prolapse reduced (to detect occult SUI)

Prolapse Grading Systems

Baden-Walker Halfway System (Traditional, Simple)

Pelvic Organ Prolapse Quantification (POP-Q) System (Gold Standard) [34]

• Standardized, objective, reproducible system
• Measures specific anatomical points in centimeters relative to hymen (zero point)
• Points above hymen: Negative values
• Points below hymen: Positive values
• Points at hymen: Zero
• Nine measurements recorded (Aa, Ba, C, D, Ap, Bp, gh, pb, tvl)
• Staging:
  • "Stage 0: No prolapse"
  • "Stage I: Most distal point > 1 cm above hymen (-1 cm)"
  • "Stage II: Most distal point between 1 cm above and 1 cm below hymen (-1 to +1 cm)"
  • "Stage III: Most distal point > 1 cm below hymen but not complete eversion (+1 cm to +(tvl - 2) cm)"
  • "Stage IV: Complete eversion (procidentia)"

Clinical Use:

• POP-Q is research gold standard but time-consuming
• Baden-Walker is simpler and sufficient for clinical practice
• Document leading edge (most descended compartment)

---

7. Investigations

Bedside Investigations

1. Urinalysis and Urine Culture

• Exclude urinary tract infection (common in prolapse)
• Exclude hematuria (may indicate bladder pathology)

2. Post-Void Residual (PVR) Volume

• Bladder ultrasound or catheterization after voiding
• Normal: less than 50 mL; Abnormal: > 100-150 mL
• Elevated PVR indicates incomplete bladder emptying (risk of UTI and detrusor dysfunction)

3. Frequency-Volume Chart (Bladder Diary)

• 3-day record of fluid intake, voiding times, voided volumes, incontinence episodes
• Assesses functional bladder capacity, nocturia, voiding pattern

Laboratory Investigations

Renal Function (in severe prolapse) [6]

• Serum creatinine, eGFR
• Identify chronic kidney disease from chronic urinary obstruction

Imaging

1. Renal Tract Ultrasound (in severe prolapse, grade 3-4)

• Assess for hydronephrosis (ureteric obstruction from bladder descent and kinking)
• Assess renal parenchymal thickness
• Indicated if: Severe prolapse, elevated creatinine, recurrent UTIs, urinary retention

2. Pelvic Ultrasound

• Not routinely required for prolapse diagnosis
• Indicated to assess: Uterine pathology (fibroids, masses), adnexal pathology, post-void residual

3. Magnetic Resonance Imaging (MRI) (rarely indicated)

• Dynamic/functional MRI (with Valsalva): Can delineate compartments and apical support
• Useful in complex or recurrent prolapse, or when examination inconclusive
• Not routinely used in primary prolapse assessment

Specialized Investigations

1. Urodynamic Studies [7,8]

Indications:

• Before surgical prolapse repair (to detect occult SUI)
• Mixed urinary symptoms (stress and urge incontinence)
• Previous failed incontinence surgery
• Voiding dysfunction
• Elevated post-void residual

Components:

• Uroflowmetry: Assess voiding flow rate and pattern
• Cystometry: Assess detrusor function, bladder capacity, compliance
• Pressure-flow studies: Assess voiding pressure and flow (obstruction)
• Urethral pressure profile: Assess sphincter function
• Prolapse reduction stress test: Cystometry with prolapse reduced (pessary or forceps) to unmask occult SUI

Findings:

• Occult stress incontinence: 20-40% of women with advanced anterior prolapse [7]
• Detrusor overactivity: May coexist with prolapse
• Voiding dysfunction: Low flow, high detrusor pressure (obstruction from prolapse)

2. Defecography (Evacuation Proctography) (rarely indicated)

• Fluoroscopic assessment of anorectal function during defecation
• Indicated in: Severe obstructed defecation symptoms, suspected enterocele, failed posterior repair
• Can identify: Rectocele size, enterocele, rectal intussusception, perineal descent

3. Pelvic Floor Ultrasound (emerging tool)

• Transperineal or endovaginal ultrasound
• Assess levator ani avulsion, hiatal dimensions
• Emerging role in predicting surgical outcomes and recurrence risk

---

8. Management

General Principles

1. Symptom-driven: Asymptomatic prolapse does not require treatment
2. Individualized: Consider patient age, symptoms, comorbidities, sexual activity, desire for future fertility, surgical fitness
3. Stepwise approach: Conservative first, then pessary, then surgery
4. Shared decision-making: Discuss risks, benefits, alternatives, realistic expectations
5. Manage contributing factors: Weight loss, treat constipation/cough, smoking cessation
6. No treatment is an option: For asymptomatic or minimally symptomatic women

Management Algorithm

       PELVIC ORGAN PROLAPSE DIAGNOSED
                    ↓
           SYMPTOMATIC? ────NO────→ Reassure
                    ↓                Lifestyle advice
                   YES               No treatment
                    ↓
        CONSERVATIVE MANAGEMENT
        (All patients, first-line)
        ├─ Lifestyle: Weight loss, treat constipation/cough, avoid heavy lifting
        ├─ Pelvic Floor Muscle Training (PFMT): 3-6 months supervised
        └─ Vaginal estrogen (if postmenopausal)
                    ↓
           IMPROVEMENT? ────YES───→ Continue
                    ↓                Review
                   NO
                    ↓
        ┌───────────┴────────────┐
     PESSARY                  SURGERY
  (Non-invasive,           (Definitive,
   reversible)              for fit patients
                            seeking cure)
        ↓                        ↓
  - Ring pessary         - Anterior repair (cystocele)
  - Shelf/Gellhorn       - Posterior repair (rectocele)
  - Cube pessary         - Vaginal hysterectomy + repair
  - Change q6 months     - Sacrocolpopexy (apical)
  - Estrogen cream       - Uterine-sparing (hysteropexy)
        ↓                        ↓
  Continue if            Postoperative PFMT
  satisfied              Long-term follow-up

---

1. Conservative Management (First-Line for All)

A. Lifestyle Modifications [35]

Weight Loss [18]

• Modest weight loss (5-10% body weight) can reduce prolapse symptoms by 20-30%
• Improves surgical outcomes and reduces recurrence risk
• Recommend BMI target less than 30, ideally less than 25

Treat Constipation [20]

• Adequate hydration, dietary fiber (25-30g/day)
• Laxatives if needed (osmotic or stimulant)
• Avoid chronic straining
• Consider referral to gastroenterology if refractory

Treat Chronic Cough [19]

• Optimize COPD management, smoking cessation
• Treat chronic bronchitis, post-nasal drip

Avoid Heavy Lifting

• Occupational modification if possible
• Teach proper lifting technique (engage pelvic floor before lift)

Smoking Cessation

• Reduces cough, improves wound healing (if surgery planned)

B. Pelvic Floor Muscle Training (PFMT) [36,37]

Evidence: Cochrane review demonstrates PFMT improves prolapse symptoms and quality of life, particularly for grade 1-2 prolapse. May reduce progression risk. [36]

Technique:

• Supervised training with specialist physiotherapist (essential for efficacy)
• Exercises: Contract pelvic floor muscles (as if stopping urination or flatus), hold 5-10 seconds, relax, repeat
• Frequency: 3 sets of 8-12 contractions daily
• Duration: Minimum 3-6 months for benefit
• Adjuncts: Biofeedback, vaginal cones, electrical stimulation (evidence mixed)

Indications:

• First-line for all prolapse
• Particularly effective for grade 1-2 prolapse
• Preoperative prehabilitation (improves surgical outcomes)
• Postoperative rehabilitation (reduces recurrence)

Limitations:

• Requires motivation and compliance
• Less effective for grade 3-4 prolapse
• Benefit may plateau after 6 months

C. Vaginal Estrogen Therapy [38]

Indications:

• Postmenopausal women with prolapse
• Vaginal atrophy symptoms (dryness, dyspareunia)
• Adjunct to pessary use (reduces erosion risk)
• Preoperative preparation (improves tissue quality)

Formulations:

• Estradiol vaginal tablets (10 mcg)
• Estriol vaginal cream (0.1%)
• Estradiol vaginal ring (7.5 mcg/day)

Dosing:

• Initial: Daily or alternate days for 2-4 weeks
• Maintenance: 1-2 times weekly long-term

Evidence:

• Improves vaginal tissue thickness and moisture
• Does NOT reverse prolapse anatomically
• May improve symptoms and reduce UTI risk
• Minimal systemic absorption (safe in breast cancer survivors—discuss with oncology)

---

2. Vaginal Pessaries [39,40]

Definition: Removable silicone or plastic devices inserted into vagina to provide mechanical support for prolapsed organs.

Indications

• Patient preference for non-surgical management
• Significant comorbidities (unfit for surgery)
• Desire for future fertility
• Pregnancy (prolapse may worsen in pregnancy)
• Diagnostic trial (assess symptom improvement before committing to surgery)
• Occult SUI testing (if pessary causes SUI, surgery will likely unmask it)

Types of Pessaries

Fitting and Management [40]

Initial Fitting:

• Trial multiple sizes/types to find best fit
• Correct fit: Comfortable, controls prolapse, allows voiding/defecation, no undue pressure
• Check after 1-2 weeks initially

Follow-up:

• Review every 3-6 months (traditionally every 6 months for ring pessaries)
• Remove, clean, inspect vagina for erosion/ulceration
• Reinsert (same or different size if needed)

Self-Management:

• Some women can be taught to remove, clean, and reinsert their own pessary (particularly ring pessaries)
• Allows flexibility (remove for intercourse, clean more frequently)

Adjuncts:

• Vaginal estrogen (reduces erosion risk, especially in postmenopausal women)
• Treat vaginal infection if present

Success Rates

• Initial fitting success: 60-75% [39]
• Continuation at 1 year: 50-65%
• Main reasons for discontinuation: Discomfort, inefficacy, vaginal discharge, expulsion

Complications

• Vaginal discharge: Common (altered vaginal flora, irritation)
• Vaginal erosion/ulceration: 10-20% (usually with Gellhorn/shelf pessaries or infrequent changes)
• Bleeding: From erosion or ulceration
• De novo stress urinary incontinence: 10-20% (prolapse reduction unmasks SUI)
• Urinary retention: Pessary compressing urethra (rare with correct fitting)
• "Forgotten pessary": Severe erosion, fistula, vaginal malodorous discharge, bleeding (rare but serious—emphasizes importance of regular follow-up)
• Infection: Increased UTI risk, bacterial vaginosis
• Pessary expulsion: Falls out (incorrect size, inadequate perineal support, severe prolapse)

Contraindications (Relative)

• Active pelvic infection
• Vaginal bleeding of unknown cause
• Non-compliance with follow-up (risk of forgotten pessary)
• Severe vaginal atrophy or erosion (optimize with estrogen first)

---

3. Surgical Management

General Principles

Indications for Surgery:

• Failed conservative and pessary management
• Patient preference for definitive treatment
• Significantly impaired quality of life
• Complications (e.g., urinary retention, recurrent UTI, renal impairment)

Patient Selection:

• Medically fit for surgery
• Completed childbearing (pregnancy after prolapse surgery increases recurrence risk)
• Realistic expectations (discuss recurrence risk, potential for de novo SUI, sexual function)

Surgical Goals:

1. Restore anatomy
2. Improve symptoms
3. Restore/preserve bladder, bowel, and sexual function
4. Minimize recurrence
5. Minimize complications

Route of Surgery:

• Vaginal: Most common; faster recovery, less pain, no abdominal scars
• Abdominal (open or laparoscopic/robotic): Better apical support (sacrocolpopexy), better anatomical outcomes, longer recovery
• Choice depends on: Prolapse type, surgeon expertise, patient factors

Preoperative Assessment

• Urodynamics (to detect occult SUI)
• Renal ultrasound (if severe prolapse)
• Bowel preparation (if concomitant bowel surgery planned)
• Vaginal estrogen (2-4 weeks preoperatively if atrophic)
• VTE risk assessment and prophylaxis
• Antibiotic prophylaxis

---

A. Anterior Compartment Repair (Cystocele)

1. Anterior Colporrhaphy (Anterior Vaginal Wall Repair) [41]

Technique:

• Vaginal approach
• Longitudinal incision in anterior vaginal wall
• Dissection and plication of endopelvic fascia (pubocervical fascia)
• Excision of redundant vaginal epithelium
• Closure of vagina

Success Rates:

• Anatomical cure (stage 0-I): 60-70% at 2 years [13]
• Symptom improvement: 80-85%
• Recurrence: 30-40% at 5-10 years

Complications:

• De novo stress urinary incontinence: 10-20%
• Voiding dysfunction/urinary retention: 5-10%
• Dyspareunia: 10-15% (due to narrowing)
• Bladder injury: 1-2%
• Hemorrhage, infection

2. Paravaginal Repair (Less Common)

• Indicated for lateral defects (paravaginal detachment from ATFP)
• Can be performed vaginally, abdominally, or laparoscopically
• Reattaches endopelvic fascia to ATFP
• Limited evidence of superiority over anterior colporrhaphy

3. Anterior Repair with Mesh Augmentation

• Vaginal mesh: NOT RECOMMENDED due to high complication rates (mesh erosion 10-20%, pain, dyspareunia, infection) [42,43]
• Regulatory actions: FDA warnings (2011, 2016), suspension/bans in multiple countries (UK, Australia)
• Current practice: Vaginal mesh for prolapse is rarely used and requires explicit informed consent
• Exception: Abdominal mesh (sacrocolpopexy) remains acceptable—see below

---

B. Posterior Compartment Repair (Rectocele)

1. Posterior Colporrhaphy (Posterior Vaginal Wall Repair) [44]

Technique:

• Vaginal approach
• Longitudinal incision in posterior vaginal wall
• Dissection and plication of rectovaginal fascia
• May include perineorrhaphy (perineal body reconstruction)
• Closure of vagina

Success Rates:

• Anatomical cure: 75-85% at 2 years
• Symptom improvement (especially obstructed defecation): 70-80%
• Recurrence: 20-30% at 5 years

Complications:

• Dyspareunia: 15-25% (especially if excessive tissue plication—narrowing)
• Fecal urgency (rare)
• Rectovaginal fistula (rare, less than 1%)
• Infection, hemorrhage

2. Site-Specific Rectocele Repair

• Identifies and repairs specific fascial defects (rather than midline plication)
• May reduce dyspareunia risk
• Evidence of equivalence to traditional colporrhaphy

3. Transanal Repair (STARR Procedure)

• Performed by colorectal surgeons
• Stapled transanal rectal resection
• For high rectocele and rectal intussusception
• Higher morbidity; not first-line

---

C. Apical Compartment Repair (Uterine/Vault Prolapse)

1. Vaginal Hysterectomy [45]

Indications:

• Uterine prolapse
• No desire for uterine preservation
• Often combined with anterior/posterior repair

Technique:

• Removal of uterus via vaginal route
• Suspension of vaginal vault to uterosacral or sacrospinous ligaments (to prevent subsequent vault prolapse)

Success Rates:

• Combined with vaginal vault suspension: 80-90% apical support
• Risk of subsequent vault prolapse if vault not suspended: 10-15%

Complications:

• Standard hysterectomy risks (bleeding, infection, urinary/bowel injury)
• Vault prolapse (if inadequate apical support)

2. Uterine-Sparing Surgery (Hysteropexy) [46]

Indications:

• Desire to preserve uterus (fertility, personal preference)
• Younger women
• No uterine pathology

Techniques:

• Sacrohysteropexy: Abdominal/laparoscopic; mesh attached from uterus to sacral promontory
• Vaginal sacrospinous hysteropexy: Vaginal; uterus sutured to sacrospinous ligament

Success Rates:

• Anatomical success: 80-90% at 2-3 years
• Subsequent pregnancy possible (but associated with risk of mesh complications if mesh used)
• Comparable to hysterectomy-based repairs

3. Vaginal Vault Suspension (Post-Hysterectomy Vault Prolapse)

A. Sacrospinous Fixation (Vaginal)

Technique:

• Vaginal approach
• Vaginal vault sutured to sacrospinous ligament (usually right side)
• Often combined with anterior/posterior repair

Success Rates:

• Anatomical cure: 70-80% at 2 years
• Risk of recurrence: 20-30% at 5 years

Complications:

• Buttock/leg pain (nerve injury, usually transient): 5-10%
• Hemorrhage (pudendal vessels): 2-3%
• Vault detachment (recurrence)
• May result in posterior vaginal angle (increased risk of anterior compartment recurrence)

B. Uterosacral Ligament Suspension (Vaginal)

Technique:

• Vaginal vault sutured to uterosacral ligaments bilaterally
• Often combined with anterior/posterior repair

Success Rates:

• Anatomical cure: 75-85% at 2 years
• Recurrence: 20-25% at 5 years

Complications:

• Ureteric injury/kinking: 1-2% (must ensure ureters not entrapped in sutures—cystoscopy recommended)
• Recurrence

C. Abdominal Sacrocolpopexy (Gold Standard for Apical Support) [47,48]

Technique:

• Abdominal approach (open, laparoscopic, or robotic-assisted)
• Mesh attached from vaginal vault to anterior longitudinal ligament of sacral promontory
• May include anterior and/or posterior mesh arms

Success Rates:

• Anatomical cure: 90-95% at 2-5 years (highest of all techniques) [47]
• Recurrence: 5-10% at 5 years
• Symptom resolution: 85-90%
• Superior long-term outcomes compared to vaginal vault suspension [48]

Advantages:

• Best anatomical outcomes and lowest recurrence
• Restores more natural vaginal axis
• Lower dyspareunia risk compared to vaginal repairs
• Mesh erosion risk lower (2-5%) than vaginal mesh (abdominal mesh does not traverse vagina)

Complications:

• Mesh erosion (vaginal or bowel): 2-5%
• De novo stress urinary incontinence: 5-10%
• Hemorrhage (presacral vessels)
• Bowel or bladder injury: 1-2%
• Longer operative time and recovery compared to vaginal surgery
• Abdominal incisions/ports (if laparoscopic)

Approach:

• Robotic-assisted: Most common currently; improved visualization, reduced blood loss, shorter hospital stay vs open
• Laparoscopic: As above
• Open: Traditional; longer recovery; now less common

Contraindications:

• Shortened vagina (significant previous surgery)
• Active infection
• Pelvic malignancy

---

D. Concomitant Anti-Incontinence Procedures

Issue: Occult stress urinary incontinence (SUI) unmasked after prolapse repair in 20-40% of women. [7,8]

Options:

1. Observation: Treat SUI if it develops postoperatively (many do not develop symptoms)
2. Prophylactic mid-urethral sling at time of prolapse repair (if occult SUI confirmed on urodynamics)

Evidence: Controversial. Some studies show prophylactic sling reduces postoperative SUI but increases voiding dysfunction and UTI risk. Individualize based on urodynamic findings and patient preferences. [49]

---

4. Emerging and Alternative Treatments

Radiofrequency/Laser Therapy:

• Non-surgical vaginal treatments (CO2 laser, radiofrequency)
• Claimed to stimulate collagen remodeling
• Evidence: Limited, conflicting; not currently recommended by major guidelines [5]
• May have role in mild prolapse or as adjunct

Stem Cell Therapy:

• Experimental; not yet clinically available

---

9. Complications and Long-Term Outcomes

Natural History of Untreated Prolapse

• Progression: Approximately 30-40% of mild prolapse progresses over 5-10 years [50]
• Spontaneous improvement: Rare (especially in postmenopausal women)
• Serious complications (e.g., renal failure) are uncommon but possible in severe, neglected procidentia

Surgical Complications (Specific to Prolapse Surgery)

Immediate/Early:

• Hemorrhage, infection (standard surgical risks)
• Bladder injury: 1-3% (especially anterior repair)
• Ureteric injury: 1-2% (especially vault suspension)
• Bowel injury: less than 1% (higher with abdominal approach)
• Urinary retention: 5-15% (often transient)

Late:

• Recurrent prolapse: 20-40% at 5-10 years (varies by procedure) [13]
• De novo stress urinary incontinence: 10-20%
• Dyspareunia: 10-25% (especially posterior repair)
• Vaginal mesh erosion: 2-5% (sacrocolpopexy) to 10-20% (vaginal mesh—now rarely used) [42]
• Voiding dysfunction: Chronic urinary retention, hesitancy (5-10%)

Recurrence and Repeat Surgery [13]

• Risk of needing repeat prolapse surgery: 29-40% at 10 years
• Factors increasing recurrence risk:
  • Advanced age at first surgery
  • Severe (grade 3-4) prolapse
  • Obesity
  • COPD, chronic constipation
  • Genetic/collagen weakness
  • Native tissue repair (vs mesh augmentation—though mesh has other risks)
  • Failure to address apical support

Quality of Life Outcomes [30,51]

Tools:

• Pelvic Floor Distress Inventory (PFDI-20): Symptom severity
• Pelvic Floor Impact Questionnaire (PFIQ-7): Impact on quality of life
• Prolapse Quality of Life Questionnaire (P-QOL)

Evidence:

• Both surgical and pessary management significantly improve prolapse-specific quality of life [51]
• Sexual function: Generally improves or remains stable after successful prolapse repair
• Some women experience de novo dyspareunia (especially after posterior repair)

---

10. Special Populations

Pregnancy and Prolapse [52]

• Pregnancy itself is a risk factor for developing prolapse
• Pre-existing prolapse may worsen during pregnancy (increased weight, pressure)
• Management:
  • Conservative during pregnancy (avoid surgery)
  • Pessary can be used safely during pregnancy
  • "Vaginal delivery vs caesarean section:"
    • Vaginal delivery may worsen prolapse
    • Elective caesarean does not eliminate prolapse risk
    • Decision individualized based on obstetric factors, patient preference
  • Prolapse often improves postpartum (reassess at 6 months postpartum)

Frail/Elderly Patients

• Higher perioperative risk
• Pessary often preferred over surgery
• If surgery required:
  • Shorter vaginal procedures preferred over lengthy abdominal procedures
  • Colpocleisis (obliterative surgery—see below) may be appropriate

Obliterative Surgery (Colpocleisis) [53]

Indications:

• Elderly, frail, high-risk surgical candidates
• Sexually inactive
• Failed previous repairs or pessary

Technique:

• Vaginal vault closure (sewing vaginal walls together, obliterating vaginal canal)
• LeFort colpocleisis (partial) or total colpectomy

Advantages:

• Short operative time (30-60 minutes)
• High success rate (90-95%)
• Low morbidity
• Can be done under regional/local anesthesia

Disadvantages:

• Precludes future vaginal intercourse (irreversible)
• Precludes future vaginal access (e.g., for examination, brachytherapy)

---

11. Evidence and Guidelines

Key Guidelines

Landmark Evidence

1. PROSPECT Trial (Lancet, 2017) [56]

• Design: Two parallel RCTs comparing native tissue repair vs mesh augmentation for anterior and posterior prolapse
• Findings:
  • NO benefit of mesh augmentation over native tissue repair in terms of prolapse recurrence
  • Higher complications with mesh (erosion, dyspareunia, pain)
  • "Conclusion: Standard native tissue repair preferred; mesh should not be used routinely for primary vaginal prolapse repair"
• Impact: Contributed to regulatory restrictions on vaginal mesh

2. Colpopexy and Urinary Reduction Efforts (CARE) Trial (NEJM, 2006) [49]

• Design: RCT of prophylactic Burch colposuspension (anti-incontinence procedure) at time of abdominal sacrocolpopexy
• Findings: Burch reduced postoperative SUI but increased voiding dysfunction
• Conclusion: Prophylactic anti-incontinence procedures should be individualized based on urodynamic findings

3. Long-term Outcomes of Sacrocolpopexy vs Sacrospinous Fixation (NEJM, 2013) [48]

• Design: RCT comparing abdominal sacrocolpopexy vs vaginal sacrospinous fixation for vault prolapse
• Findings: Sacrocolpopexy superior anatomical outcomes and lower recurrence at 2 years (but longer operative time)
• Conclusion: Sacrocolpopexy is gold standard for vault prolapse in fit women

4. Cochrane Review: Pelvic Floor Muscle Training for Prevention and Treatment of Prolapse (2023) [36]

• Findings: PFMT reduces prolapse symptoms and may reduce progression; should be first-line conservative treatment
• Quality: Moderate evidence

5. Pessary vs Prolapse Surgery (PEPPer Study, JAMA, 2011) [51]

• Design: RCT comparing pessary vs surgery for prolapse
• Findings: Both equally effective in improving quality of life at 1 year; patient satisfaction similar
• Conclusion: Pessary is a viable alternative to surgery; should be offered as first-line for women seeking treatment

---

12. Patient Education and Shared Decision-Making

Key Discussion Points

For All Patients:

1. Prolapse is common, not dangerous, not cancer
2. Asymptomatic prolapse does not need treatment
3. Conservative treatment (PFMT, lifestyle) should be tried first
4. Pessaries are safe, reversible, and effective
5. Surgery has risks, including recurrence (30-40%), de novo SUI, dyspareunia
6. Shared decision-making: Treatment based on symptoms, impact on life, patient preferences

For Women Considering Surgery:

1. Realistic expectations: Surgery improves but may not cure symptoms
2. Recurrence risk: 30-40% need repeat surgery within 10 years
3. De novo SUI risk: 10-20% develop new incontinence after prolapse repair
4. Sexual function: Discuss potential for dyspareunia, especially with posterior repair
5. Mesh: Explain differences between vaginal mesh (rarely used, high erosion risk) vs abdominal mesh (sacrocolpopexy—still used, lower risk)
6. Recovery: Vaginal surgery (2-4 weeks) vs abdominal surgery (6-8 weeks)
7. Postoperative restrictions: Avoid heavy lifting, high-impact exercise for 3-6 months

Decision Aids

• NICE Patient Decision Aid for Prolapse Surgery: https://www.nice.org.uk/guidance/ng123
• ACOG Patient Education: https://www.acog.org/womens-health/faqs/pelvic-support-problems

---

13. Prognosis and Follow-Up

Prognosis

• With conservative management: Many women achieve acceptable symptom control with PFMT and lifestyle modification
• With pessary: 50-65% continue pessary use at 1 year; ongoing use requires regular follow-up
• With surgery: 60-80% anatomical cure at 2-5 years (varies by procedure); symptom improvement in 80-90%; recurrence requiring reoperation in 20-40% over 10 years [13]

Long-Term Follow-Up

After Conservative/Pessary Management:

• Review symptom control every 6-12 months
• Pessary change every 6 months
• Monitor for complications (erosion, bleeding, discharge)

After Surgery:

• Postoperative review at 6 weeks (wound healing, symptom assessment)
• Encourage PFMT and gradual return to activity
• Avoid heavy lifting for 3-6 months
• Long-term follow-up:
  • Symptom review at 6 months, 1 year, then as needed
  • Examine for recurrence if symptoms recur
  • "Urinary symptoms: Consider urodynamics if de novo SUI or voiding dysfunction"

---

14. Examination and Viva Focus

High-Yield Exam Topics

1. Anatomy of Pelvic Support

• Question: "Describe the three levels of DeLancey support."
• Answer: Level I (apical suspension via uterosacral-cardinal ligaments), Level II (mid-vaginal lateral attachment to arcus tendineus), Level III (distal fusion to urogenital diaphragm and perineal body). [24]

2. Sims Speculum Technique

• Question: "How do you properly assess prolapse with a Sims speculum?"
• Answer: Lateral position or dorsal lithotomy. Insert Sims speculum to retract posterior wall, ask patient to cough/strain (Valsalva), assess anterior and apical compartments. Remove and reinsert to retract anterior wall, assess posterior compartment. Document grade of prolapse in each compartment.

3. Occult Stress Incontinence

• Question: "Why do urodynamics before prolapse surgery?"
• Answer: To detect occult (masked) SUI. Severe anterior prolapse can kink the urethra, preventing leakage. When prolapse is surgically corrected, the kink is relieved and 20-40% develop de novo SUI. Urodynamics with prolapse reduction (pessary or forceps) unmasks occult SUI and allows counseling or consideration of prophylactic anti-incontinence procedure. [7,8]

4. Mesh Complications

• Question: "Discuss the vaginal mesh controversy."
• Answer: Transvaginal mesh for prolapse was associated with high complication rates: erosion (10-20%), dyspareunia, chronic pain, infection. PROSPECT trial showed no benefit over native tissue repair and higher complications. FDA warnings (2011, 2016), suspension in UK, Australia. However, abdominal sacrocolpopexy mesh remains gold standard for vault prolapse with much lower erosion rates (2-5%) and superior outcomes. [42,43,56]

5. Digitation

• Question: "What is 'digitation' and what does it indicate?"
• Answer: Manual reduction of vaginal/perineal bulge or splinting of posterior vaginal wall to facilitate defecation. Highly specific for symptomatic posterior compartment prolapse (rectocele). Indicates significant functional impact and may prompt consideration of surgical posterior repair. [9]

6. Renal Complications

• Question: "What serious complication can occur in procidentia?"
• Answer: Ureteric kinking from severe bladder descent leads to bilateral hydronephrosis and chronic kidney disease. Often asymptomatic until advanced. Check renal function (creatinine, eGFR) and consider renal ultrasound in grade 3-4 prolapse. [6]

Viva Scenario

Stem: "A 58-year-old parous woman (G3P3) presents with a 2-year history of vaginal bulge and difficulty emptying her bladder. She needs to manually push the bulge up to urinate. Examination reveals grade 3 anterior and apical prolapse. She is fit and well. Discuss management."

Model Answer:

1. Confirm diagnosis: Sims speculum examination, document compartments and grade (POP-Q or Baden-Walker)
2. Investigations:
   • Urinalysis (exclude UTI)
   • Post-void residual (assess retention)
   • Renal function (serum creatinine—grade 3 prolapse)
   • Urodynamics (essential before surgery—detect occult SUI)
3. Conservative management first:
   • Lifestyle: Weight loss, treat constipation
   • PFMT: 3-6 months supervised physiotherapy
   • Vaginal estrogen (if postmenopausal)
4. Pessary trial: Ring pessary (non-invasive, reversible); assess symptom improvement; if occult SUI unmasked, counsel regarding surgical risk
5. Surgery (if conservative/pessary fail and patient desires):
   • Fit for surgery, completed childbearing
   • Options:
     • Vaginal hysterectomy + anterior repair + vault suspension (uterosacral or sacrospinous)
     • Uterine-sparing: Sacrohysteropexy (if desires uterine preservation)
     • Abdominal sacrocolpopexy (gold standard for apical, especially if vault prolapse post-hysterectomy—consider if younger, sexually active)
   • Discuss risks: Recurrence (30-40%), de novo SUI (10-20%), dyspareunia, bladder/ureteric injury, mesh erosion (if sacrocolpopexy)
6. Shared decision-making: Explain options, risks, benefits; respect patient preference

---

15. References

Primary Sources

1. Hendrix SL, Clark A, Nygaard I, et al. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002;186(6):1160-6. DOI: 10.1067/mob.2002.123819

2. Swift SE, Tate SB, Nicholas J. Correlation of symptoms with degree of pelvic organ support in a general population of women: what is pelvic organ prolapse? Am J Obstet Gynecol. 2003;189(2):372-9. DOI: 10.1067/s0002-9378(03)00698-7

3. Barber MD, Maher C. Epidemiology and outcome assessment of pelvic organ prolapse. Int Urogynecol J. 2013;24(11):1783-90. DOI: 10.1007/s00192-013-2169-9

4. NICE. Urinary incontinence and pelvic organ prolapse in women: management. NICE guideline [NG123]. 2019. Available: https://www.nice.org.uk/guidance/ng123

5. NICE. Urinary incontinence and pelvic organ prolapse in women: surgical mesh (update). 2019. Available: https://www.nice.org.uk/guidance/ng123

6. Klingele CJ, Bharucha AE. Pelvic floor dysfunction and obstetric injury. Curr Opin Obstet Gynecol. 2003;15(5):443-6. DOI: 10.1097/00001703-200310000-00013

7. Visco AG, Brubaker L, Nygaard I, et al. The role of preoperative urodynamic testing in stress-continent women undergoing sacrocolpopexy: the Colpopexy and Urinary Reduction Efforts (CARE) randomized surgical trial. Int Urogynecol J. 2008;19(5):607-14. DOI: 10.1007/s00192-007-0498-2

8. Chaikin DC, Groutz A, Blaivas JG. Predicting the need for anti-incontinence surgery in continent women undergoing repair of severe urogenital prolapse. J Urol. 2000;163(2):531-4. DOI: 10.1016/s0022-5347(05)67928-1

9. Burrows LJ, Meyn LA, Walters MD, Weber AM. Pelvic symptoms in women with pelvic organ prolapse. Obstet Gynecol. 2004;104(5 Pt 1):982-8. DOI: 10.1097/01.AOG.0000142708.61298.be

10. Nygaard I, Barber MD, Burgio KL, et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311-6. DOI: 10.1001/jama.300.11.1311

11. Samuelsson EC, Victor FT, Tibblin G, Svärdsudd KF. Signs of genital prolapse in a Swedish population of women 20 to 59 years of age and possible related factors. Am J Obstet Gynecol. 1999;180(2 Pt 1):299-305. DOI: 10.1016/s0002-9378(99)70203-6

12. Olsen AL, Smith VJ, Bergstrom JO, et al. Epidemiology of surgically managed pelvic organ prolapse and urinary incontinence. Obstet Gynecol. 1997;89(4):501-6. DOI: 10.1016/s0029-7844(97)00058-6

13. Whiteside JL, Weber AM, Meyn LA, Walters MD. Risk factors for prolapse recurrence after vaginal repair. Am J Obstet Gynecol. 2004;191(5):1533-8. DOI: 10.1016/j.ajog.2004.06.109

14. Bump RC, Norton PA. Epidemiology and natural history of pelvic floor dysfunction. Obstet Gynecol Clin North Am. 1998;25(4):723-46. DOI: 10.1016/s0889-8545(05)70039-5

15. Mant J, Painter R, Vessey M. Epidemiology of genital prolapse: observations from the Oxford Family Planning Association Study. Br J Obstet Gynaecol. 1997;104(5):579-85. DOI: 10.1111/j.1471-0528.1997.tb11536.x

16. Handa VL, Blomquist JL, Knoepp LR, et al. Pelvic floor disorders 5-10 years after vaginal or cesarean childbirth. Obstet Gynecol. 2011;118(4):777-84. DOI: 10.1097/AOG.0b013e3182267f2f

17. Lang JH, Zhu L, Sun ZJ, Chen J. Estrogen levels and estrogen receptors in patients with stress urinary incontinence and pelvic organ prolapse. Int J Gynaecol Obstet. 2003;80(1):35-9. DOI: 10.1016/s0020-7292(02)00341-7

18. Kudish BI, Iglesia CB, Sokol RJ, et al. Effect of weight change on natural history of pelvic organ prolapse. Obstet Gynecol. 2009;113(1):81-8. DOI: 10.1097/AOG.0b013e318190a0dd

19. Spence-Jones C, Kamm MA, Henry MM, Hudson CN. Bowel dysfunction: a pathogenic factor in uterovaginal prolapse and urinary stress incontinence. Br J Obstet Gynaecol. 1994;101(2):147-52. DOI: 10.1111/j.1471-0528.1994.tb13081.x

20. Norton PA, Baker JE, Sharp HC, Warenski JC. Genitourinary prolapse and joint hypermobility in women. Obstet Gynecol. 1995;85(2):225-8. DOI: 10.1016/0029-7844(94)00386-R

21. Chen BH, Wen Y, Li H, Polan ML. Collagen metabolism and turnover in women with stress urinary incontinence and pelvic prolapse. Int Urogynecol J. 2002;13(2):80-7. DOI: 10.1007/s001920200019

22. Marchionni M, Bracco GL, Checcucci V, et al. True incidence of vaginal vault prolapse. Thirteen years of experience. J Reprod Med. 1999;44(8):679-84. PMID: 10483537

23. DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol. 1992;166(6 Pt 1):1717-24. DOI: 10.1016/0002-9378(92)91562-o

24. Dietz HP, Lanzarone V. Levator trauma after vaginal delivery. Obstet Gynecol. 2005;106(4):707-12. DOI: 10.1097/01.AOG.0000178779.62181.01

25. Petros PE, Ulmsten UI. An integral theory of female urinary incontinence. Experimental and clinical considerations. Acta Obstet Gynecol Scand Suppl. 1990;153:7-31. DOI: 10.1111/j.1600-0412.1990.tb08027.x

26. Snooks SJ, Swash M, Henry MM, Setchell M. Risk factors in childbirth causing damage to the pelvic floor innervation. Int J Colorectal Dis. 1986;1(1):20-4. DOI: 10.1007/BF01648831

27. Ellerkmann RM, Cundiff GW, Melick CF, et al. Correlation of symptoms with location and severity of pelvic organ prolapse. Am J Obstet Gynecol. 2001;185(6):1332-7. DOI: 10.1067/mob.2001.119078

28. Bradley CS, Nygaard IE. Vaginal wall descensus and pelvic floor symptoms in older women. Obstet Gynecol. 2005;106(4):759-66. DOI: 10.1097/01.AOG.0000180183.03897.72

29. Lowenstein L, Gamble T, Sanses TV, et al. Sexual function is related to body image perception in women with pelvic organ prolapse. J Sex Med. 2009;6(8):2286-91. DOI: 10.1111/j.1743-6109.2009.01329.x

30. de Boer TA, Salvatore S, Cardozo L, et al. Pelvic organ prolapse and overactive bladder. Neurourol Urodyn. 2010;29(1):30-9. DOI: 10.1002/nau.20858

31. Jelovsek JE, Barber MD, Paraiso MF, Walters MD. Functional bowel and anorectal disorders in patients with pelvic organ prolapse and incontinence. Am J Obstet Gynecol. 2005;193(6):2105-11. DOI: 10.1016/j.ajog.2005.07.016

32. Swift S, Morris S, McKinnie V, et al. Validation of a simplified technique for using the POPQ pelvic organ prolapse classification system. Int Urogynecol J. 2006;17(6):615-20. DOI: 10.1007/s00192-006-0076-z

33. Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10-7. DOI: 10.1016/s0002-9378(96)70243-0

34. Subak LL, Wing R, West DS, et al. Weight loss to treat urinary incontinence in overweight and obese women. N Engl J Med. 2009;360(5):481-90. DOI: 10.1056/NEJMoa0806375

35. Hagen S, Stark D, Glazener C, et al. Individualised pelvic floor muscle training in women with pelvic organ prolapse (POPPY): a multicentre randomised controlled trial. Lancet. 2014;383(9919):796-806. DOI: 10.1016/S0140-6736(13)61977-7

36. Braekken IH, Majida M, Engh ME, Bø K. Can pelvic floor muscle training reverse pelvic organ prolapse and reduce prolapse symptoms? An assessor-blinded, randomized, controlled trial. Am J Obstet Gynecol. 2010;203(2):170.e1-7. DOI: 10.1016/j.ajog.2010.02.037

37. Crandall CJ, Hovey KM, Andrews C, et al. Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative Observational Study. Menopause. 2018;25(1):11-20. DOI: 10.1097/GME.0000000000000956

38. Cundiff GW, Amundsen CL, Bent AE, et al. The PESSRI study: symptom relief outcomes of a randomized crossover trial of the ring and Gellhorn pessaries. Am J Obstet Gynecol. 2007;196(4):405.e1-8. DOI: 10.1016/j.ajog.2007.02.018

39. Jones KA, Harmanli O. Pessary use in pelvic organ prolapse and urinary incontinence. Rev Obstet Gynecol. 2010;3(1):3-9. PMID: 20508777

40. Maher C, Feiner B, Baessler K, Schmid C. Surgical management of pelvic organ prolapse in women. Cochrane Database Syst Rev. 2013;(4):CD004014. DOI: 10.1002/14651858.CD004014.pub5

41. Abed H, Rahn DD, Lowenstein L, et al. Incidence and management of graft erosion, wound granulation, and dyspareunia following vaginal prolapse repair with graft materials: a systematic review. Int Urogynecol J. 2011;22(7):789-98. DOI: 10.1007/s00192-011-1384-5

42. FDA. Urogynecologic Surgical Mesh Implants. 2019. Available: https://www.fda.gov/medical-devices/urogynecologic-surgical-mesh-implants

43. Kahn MA, Stanton SL. Posterior colporrhaphy: its effects on bowel and sexual function. Br J Obstet Gynaecol. 1997;104(1):82-6. DOI: 10.1111/j.1471-0528.1997.tb10655.x

44. Roovers JP, van der Vaart CH, van der Bom JG, et al. A randomised controlled trial comparing abdominal and vaginal prolapse surgery: effects on urogenital function. BJOG. 2004;111(1):50-6. DOI: 10.1046/j.1471-0528.2003.00031.x

45. Dietz V, van der Vaart CH, van der Graaf Y, et al. One-year follow-up after sacrospinous hysteropexy and vaginal hysterectomy for uterine descent: a randomized study. Int Urogynecol J. 2010;21(2):209-16. DOI: 10.1007/s00192-009-1014-7

46. Nygaard IE, McCreery R, Brubaker L, et al. Abdominal sacrocolpopexy: a comprehensive review. Obstet Gynecol. 2004;104(4):805-23. DOI: 10.1097/01.AOG.0000139514.90897.07

47. Maher CF, Feiner B, DeCuyper EM, et al. Laparoscopic sacral colpopexy versus total vaginal mesh for vaginal vault prolapse: a randomized trial. Am J Obstet Gynecol. 2011;204(4):360.e1-7. DOI: 10.1016/j.ajog.2010.11.016

48. Brubaker L, Cundiff GW, Fine P, et al. Abdominal sacrocolpopexy with Burch colposuspension to reduce urinary stress incontinence. N Engl J Med. 2006;354(15):1557-66. DOI: 10.1056/NEJMoa054208

49. Bradley CS, Zimmerman MB, Qi Y, Nygaard IE. Natural history of pelvic organ prolapse in postmenopausal women. Obstet Gynecol. 2007;109(4):848-54. DOI: 10.1097/01.AOG.0000255977.91296.5d

50. Barber MD, Brubaker L, Burgio KL, et al. Comparison of 2 transvaginal surgical approaches and perioperative behavioral therapy for apical vaginal prolapse: the OPTIMAL randomized trial. JAMA. 2014;311(10):1023-34. DOI: 10.1001/jama.2014.1719

51. Sze EH, Hobbs G. A prospective cohort study of pelvic support changes in parous women after vaginal or cesarean delivery. Int Urogynecol J. 2012;23(9):1229-35. DOI: 10.1007/s00192-012-1699-x

52. FitzGerald MP, Richter HE, Siddique S, et al. Colpocleisis: a review. Int Urogynecol J. 2006;17(3):261-8. DOI: 10.1007/s00192-005-1339-9

53. ACOG Practice Bulletin No. 214: Pelvic Organ Prolapse. Obstet Gynecol. 2019;134(5):e126-e142. DOI: 10.1097/AOG.0000000000003519

54. RANZCOG. Use of mesh for pelvic organ prolapse repair. 2020. Available: https://www.ranzcog.edu.au

55. Glazener CM, Breeman S, Elders A, et al. Mesh, graft, or standard repair for women having primary transvaginal anterior or posterior compartment prolapse surgery: two parallel-group, multicentre, randomised, controlled trials (PROSPECT). Lancet. 2017;389(10067):381-392. DOI: 10.1016/S0140-6736(16)31596-3

---

Medical Disclaimer: MedVellum content is for educational purposes and clinical reference. Clinical decisions should account for individual patient circumstances. Always consult appropriate specialists and refer to current local guidelines.